The Versius surgical robot. [Image courtesy of CMR Surgical]

Versius手术机器人。[图片来源：CMR Surgical]

CMR Surgical

CMR外科手术公司

today announced that more than 30,000 surgical cases around the world have been completed using its Versius system.

今天宣布，全球已有超过30,000例手术使用其Versius系统完成。

The company said this milestone solidifies Versius’ position as the second-most utilized soft-tissue surgical robot on the market.

该公司表示，这一里程碑巩固了Versius作为市场上第二大最常用软组织手术机器人的地位。

CMR Surgical designed Versius to enable surgeons to perform more minimal access surgery. Its minimally invasive approach assists surgeons in accessing the lungs, thymus and esophagus.

CMR Surgical 设计 Versius 的目的是让外科医生能够进行更多的微创手术。其微创方法有助于外科医生接触肺部、胸腺和食道。

The system won FDA clearance in October

该系统于十月获得FDA批准

. CMR Surgical also launched enhancements for the system,

CMR Surgical 还推出了该系统的增强功能，

including the Ultrasonic Dissector

包括超声波解剖器在内的

, late last year.

，去年年底。

The small-scale surgical robotic system features collaborative arms and bedside units for direct patient access. It also features offers of port placement to best suit the needs of each patient. CMR Surgical aims for Versius to biomimic the human arm. It features 3D HD vision, easy-to-adopt instrument control and a choice of ergonomic working positions.

这种小型外科手术机器人系统具有协作臂和床旁单元，可直接接触患者。它还提供了端口放置方案，以最好地满足每位患者的需求。CMR Surgical希望Versius能够仿生人类手臂。该系统具备3D高清视觉、易于采用的器械控制以及符合人体工学的工作姿势选择。

Its open console could potentially reduce stress and fatigue while allowing for clear communication with the surgical team..

其开放的控制台可以潜在地减轻压力和疲劳，同时允许与手术团队进行清晰的沟通。

CMR Surgical said more than 70% of hospitals that utilized Versius for these cases used it across two or more specialties. Its uses extend to urology, general surgery, gynecology and thoracic surgery. The company also has clinical trials underway for pediatric surgery and in transoral robotic surgery (TORS) in the UK..

CMR Surgical 表示，超过70%的医院在这些病例中使用了Versius，且其应用横跨两个或更多专科。该系统已扩展到泌尿科、普通外科、妇科和胸外科。该公司还在英国进行儿科手术以及经口机器人手术（TORS）的临床试验。

“We are proud that over 30,000 patients around the world have now benefited from Versius, as we continue to grow and deliver against our mission of transforming surgery; for good,” said CMR Surgical CEO Massimiliano Colella. “This milestone is thanks to the surgeons and hospitals who have adopted Versius with the aim of improving patient care, and our dedicated employees who are committed to giving our customers the best experience.”.

“我们感到自豪的是，全球已有超过30,000名患者受益于Versius，我们继续成长并践行我们改善手术的使命；这是永久性的，”CMR Surgical首席执行官马西米利亚诺·科尔莱拉表示。“这一里程碑要归功于采用Versius以改善患者护理的外科医生和医院，以及致力于为客户提供最佳体验的我们敬业的员工。”